SCHEMBL29744544

SCHEMBL29744544

CC(C)(C)OC(=O)N1CC(F)(F)CC1c1cccc(F)c1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 2/20 0.50
NTRK1 P04629 2/20 0.47
JAK2 O60674 1/20 0.47
PDE5A O76074 1/20 0.42
GPR119 Q8TDV5 1/20 0.39
MAOB P27338 2/20 0.39
NR1H2 P55055 5/20 0.39
NR1H3 Q13133 4/20 0.39
OPRK1 P41145 1/20 0.39
MAOA P21397 1/20 0.39
TACR1 P25103 3/20 0.38
RXRA P19793 2/20 0.38
ROCK2 O75116 1/20 0.38
GHSR Q92847 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21723215 1.00 RIPK1 (0.50) RIPK1NTRK1JAK2PDE5AGPR119
SCHEMBL451781 1.00 RIPK1 (0.50) RIPK1NTRK1JAK2PDE5AGPR119
SCHEMBL430829 1.00 RIPK1 (0.50) RIPK1NTRK1JAK2PDE5AGPR119
SCHEMBL18588959 0.83 NTRK1 (0.41) NTRK1JAK2TACR1
SCHEMBL28537667 0.83 NTRK1 (0.41) NTRK1JAK2TACR1
SCHEMBL24526756 0.82 TACR1 (0.35) RIPK1NTRK1JAK2PDE5ANR1H2
SCHEMBL29759291 0.82 TACR1 (0.35) RIPK1NTRK1JAK2PDE5ANR1H2
SCHEMBL21313037 0.81 NTRK1 (0.41) NTRK1JAK2GPR119NR1H2NR1H3
SCHEMBL25315864 0.81 RIPK1 (0.45) RIPK1NTRK1JAK2PDE5AMAOB
SCHEMBL24527025 0.80 UCHL1 (0.38) RIPK1NTRK1JAK2NR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4259620-A1 ALDEHYDE DEHYDROGENASE INHIBITORS AND THEIR THERAPEUTIC USE Cancer Research Technology Limited (GB) 2023-10-18 EP disclosed
WO-2022123039-A1 ALDEHYDE DEHYDROGENASE INHIBITORS AND THEIR THERAPEUTIC USE CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2022-06-16 WO disclosed